| Authors: |
Roy AM; Ohio State Comprehensive Cancer Center, Columbus, OH., Bakouny Z; Memorial Sloan Kettering Cancer Center, New York, NY., Dizman N; The University of Texas MD Anderson Cancer Center, Houston, TX., Paul MA; Dana-Farber Cancer Institute, Boston, MA., Ozay ZI; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT., Lal BM; University of Arkansas for Medical Sciences, Little Rock, AR., Nawfal R; Dana-Farber Cancer Institute, Boston, MA., Eid M; Dana-Farber Cancer Institute, Boston, MA., Chehade REH; Dana-Farber Cancer Institute, Boston, MA., Machaalani M; Dana-Farber Cancer Institute, Boston, MA., Butt A; Yale University, New Haven, CT., Aggarwal C; Perelman School of Medicine at the University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA., Bekaii-Saab T; Mayo Clinic Comprehensive Cancer Center, Phoenix, AZ., Chavez-MacGregor M; The University of Texas MD Anderson Cancer Center, Houston, TX., Lopes G; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Marshall AL; University of Minnesota, Minneapolis, MN., Murphy M; University of Florida, Gainesville, FL., Owonikoko T; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD., Xie W; Dana-Farber Cancer Institute, Boston, MA., Lee AI; Yale University, New Haven, CT., Choueiri TK; Dana-Farber Cancer Institute, Boston, MA. |
